Session G: Monitoring HCV elimination among PWID (EMCDDA sponsored session)
Tracks
.
Wednesday, September 19, 2018 |
4:15 PM - 5:45 PM |
Sala II |
Speaker
Mr Thomas Seyler
Analyst
EMCDDA
Dr Hannah Fraser
Senior Research Associate In Infectious Disease Mathematical Modelling
University Of Bristol
Model projections of the impact of HCV treatment on chronic HCV in European settings
4:30 PM - 4:45 PMBiography
MD PhD Esther Croes
Senior Research Associate
Trimbos Institute
Professor, Md, Phd Mojca Maticic
Head Of Hepatitis Department
Clinic For Infectious Diseases And Febrile Illnesses, Univesity Medical Centre Ljubljana, Slovenia
Towards HCV elimination in PWID in Slovenia: how to monitor a real-life situation?
5:00 PM - 5:15 PMBiography
Dr Ruth Zimmermann
Senior Epidemiologist
Robert Koch Institute
Questions & Discussion
Questions & Discussion
5:20 PM - 5:45 PMBiography
Chair
Antons Mozalevskis
Medical Officer
WHO Regional Office For Europe